ST-segment Elevation Myocardial Infarction Clinical Trial
— CAPRIOfficial title:
Cardioprotective Effects of Remote Ischemic Perconditioning in Patients With ST-segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
Verified date | November 2021 |
Source | Yonsei University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To evaluate whether remote ischemic per-conditioning (RIPC) can reduce infarct size in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention (PPCI) within 12 hours of symptoms onset. - Control group: PPCI only - Study group: PPCI + RIPC Primary endpoint: Infarct size measured by contrast-enhanced cardiac magnetic resonance (CMR) at 6 months after the index procedure
Status | Completed |
Enrollment | 118 |
Est. completion date | January 31, 2018 |
Est. primary completion date | July 31, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years and older |
Eligibility | Inclusion Criteria: - Age >19 years - Presenting within 12 hours of symptom onset - >20 min of chest pain - ST-elevation myocardial infarction defined as ST-segment elevation (>0.1 mV) in at least 2 contiguous precordial leads Exclusion Criteria: - Previous myocardial infarction - Presence of chronic total occlusion - Evidence of retrograde filling by collaterals at coronary angiography (Rentrop 2 or 3 collateral flow) - Severe multi-vessel coronary artery disease to require further interventions before follow-up CMR - Cardiac arrest before randomization - Arrhythmias requiring external electric shock before randomization - Unwillingness to participate - External electric shock for cardioversion within first 3 days - Cardiac surgery within first 3 days |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Wonju Severance Christian Hospital | Wonju | Gangwon |
Lead Sponsor | Collaborator |
---|---|
Yonsei University |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Infarct size measured by contrast-enhanced cardiac magnetic resonance | Infarct size will be assessed on late-contrast images (˜10 min after gadolinium administration) by manually tracing the hyperintense area in each short-axis slice. | 6 months after index procedure | |
Secondary | Enzymatic Infarct Size | Enzymatic infarct size will be assessed by the area under the curve of creatine kinase-myocardial band (CK-MB) and troponin I (TnI) release. Blood samples will be collected before PCI and every day after index PPCI. Area under the curve of CK-MB and troponin I release will be expressed in arbitrary units and calculated with the trapezoidal method. | 1 to 5 days after index procedure | |
Secondary | Resolution of ST-segment deviation | ST-segment deviation score will be measured in 12-lead electrocardiograms, calculated as the sum (in millimeters) of ST-segment deviation (elevation or depression) at 80 ms after the J-point in all 12 leads. ST-segment deviation score will be measured at presentation and 30 min after PCI, by 2 physicians blinded as to the patients' data, and the mean value of the 2 assessments will be used. ST-segment resolution will be calculated as a percentage: ratio of the reduction in ST-segment deviation score from presentation to half an hour after PCI over the ST-segment deviation score at presentation × 100% (i.e., [(ST-segment deviation at presentation - ST-segment deviation post-PCI)/ST-segment deviation at presentation] × 100%). Full ST-segment resolution will be defined as 80% or more reduction of ST-segment deviation score. | 1 to 5 days after index procedure | |
Secondary | Acute kidney injury | Acute kidney injury will be defined as an absolute increase in serum creatinine of =0.5 mg/dl or a relative increase of =25% compared with baseline within 96 h after PCI (the maximal measured concentration of serum creatinine during these 96 h will be used). Relative reduction in estimated glomerular filtration rate (eGFR), calculated with the Modification of Diet in Renal Disease formula, within 96 h after PCI will be assessed. | 1 to 3 days after index procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05669222 -
The FAVOR V AMI Trial
|
N/A | |
Recruiting |
NCT02894138 -
Optimal Coronary Flow After PCI for Myocardial Infarction - a Pilot Study
|
Phase 3 | |
Completed |
NCT02641262 -
Henan STEMI Registry
|
||
Completed |
NCT01826552 -
Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent
|
Phase 4 | |
Recruiting |
NCT01738100 -
Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary Intervention
|
Phase 2 | |
Completed |
NCT05895123 -
Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients
|
Phase 2 | |
Completed |
NCT03671603 -
Post-Marketing Safety Study in ST-Segment Elevation Myocardial Infarction (STEMI) Participants Undergoing Primary Percutaneous Coronary Intervention (PCI) Procedure With VISIPAQUE® as the Contrast Medium
|
||
Recruiting |
NCT02606435 -
Thrombus Aspiration in Patients With STEMI
|
Phase 4 | |
Completed |
NCT01203982 -
Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Carotid Intima-media Thickness (CIMT)
|
Phase 4 | |
Active, not recruiting |
NCT03338309 -
INsTantenous wavE-Free Ratio-guided PCI Versus Fractional Flow REserve-Guided PCI in rouTine Clinical Practice, Prospective, Multicenter Registry
|
||
Recruiting |
NCT02445885 -
Late Reperfusion With Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction
|
N/A | |
Not yet recruiting |
NCT04984915 -
The Usefulness of CaIMR in Patients With STEMI
|
||
Active, not recruiting |
NCT03371784 -
The Effect of Glucocorticoid Therapy on Left Ventricular Remodelling in Acute Myocardial Infarction (RECONSIDER)
|
Phase 2/Phase 3 | |
Completed |
NCT03389503 -
Comparison of Left and Right Transradial Approach for CAG and PCI
|
N/A | |
Completed |
NCT02311231 -
Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART
|
Phase 4 | |
Completed |
NCT02324348 -
Efficacy and Safety Study of Deferred Stenting in Patients With STEMI
|
N/A | |
Completed |
NCT01385631 -
Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.
|
Phase 4 | |
Completed |
NCT03690713 -
International Collaboration of Comprehensive Physiologic Assessment
|
||
Enrolling by invitation |
NCT02670005 -
Fractional Flow Reserve Versus Angiography for Guiding Selective Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction
|
N/A | |
Active, not recruiting |
NCT02070471 -
Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients
|
Phase 2 |